Research programme: plasminogen-related peptides - Bio-Technology General/MGH

Drug Profile

Research programme: plasminogen-related peptides - Bio-Technology General/MGH

Alternative Names: Plasminogen-related peptide research programme - Bio-Technology General/MGH; PRP research programme - BTG/Massacheussetts General Hospital; Research programme: PRP - BTG/Massacheusetts General Hospital

Latest Information Update: 28 Dec 2000

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Massachusetts General Hospital
  • Developer Massachusetts General Hospital; Savient Pharmaceuticals
  • Class
  • Mechanism of Action Angiogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 28 Dec 2000 Discontinued-Preclinical for Solid tumours in Israel (Unknown route)
  • 28 Dec 2000 Discontinued-Preclinical for Solid tumours in USA (Unknown route)
  • 30 Jul 1999 Preclinical development for Solid tumours in Israel (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top